Y-Mabs Therapeutics Inc

NASDAQ:YMAB   4:00:00 PM EDT
4.18
-0.01 (-0.24%)
4:02:32 PM EDT: $4.18 0.00 (0.00%)
Earnings Announcements

Y-mAbs Reports Third Quarter 2022 Financial Results, Recent Corporate Developments

Published: 11/07/2022 22:05 GMT
Y-Mabs Therapeutics Inc (YMAB) - Y-mabs Reports Third Quarter 2022 Financial Results and Recent Corporate Developments.
Cash Position of $114.5 Million As of September 30, 2022, Anticipated Runway Into Mid-2024.
Reported a Net Loss for Quarter Ended September 30, 2022 of $27.5 Million, Or $0.63 per Basic and Diluted Share.
Q3 Earnings per Share View $-0.71 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $19.61 Million
Adjusted EPS is expected to be -$0.49

Next Quarter Revenue Guidance is expected to be $15.62 Million
Next Quarter EPS Guidance is expected to be -$0.44

More details on our Analysts Page.